Clinical Trial Update: Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 study of talimogene laherparepvec with chemotherapy and radiation before surgery in locally advanced or metastatic rectal cancer; the trial was terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Adenocarcinoma
• Rectal Cancer

Drugs mentioned

• Imlygic (Talimogene laherparepvec)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Locally Advanced Rectal Adenocarcinoma, Metastatic Rectal Adenocarcinoma | Phase 1 | Status: TERMINATED | Results posted: 2024-05-01